Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.

被引：0
|
作者：
Faustman, Denise L.
Torrey, Heather
Butterworth, John
Mera, Toshi
Okubo, Yoshiaki
Wang, Limei
Baum, Danielle
Warden, Sara
Plager, Sarah
Huang, Daniel
Vanamee, Eva
Foster, Rosemary
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 07期
关键词：
D O I：
10.1200/JCO.2017.35.7_suppl.106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106
引用
收藏
页数：1
相关论文
共 50 条
  • [41] TNFR2: Role in Cancer Immunology and Immunotherapy
    Yang, Yang
    Islam, Md Sahidul
    Hu, Yuanjia
    Chen, Xin
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 103 - 122
  • [42] TNFR2: A Novel Target for Cancer Immunotherapy
    Vanamee, Eva S.
    Faustman, Denise L.
    TRENDS IN MOLECULAR MEDICINE, 2017, 23 (11) : 1037 - 1046
  • [43] TNFR2 positivity identifies B cells with regulatory function
    Ticha, O.
    Slanina, P.
    Bekeredjian-Ding, I.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 23 - 23
  • [44] Dissecting the mechanism of action targeting TNFR2 with a lignd blocking anti-TNFR2 antibody that elicits potent anti-tumor activity.
    Zhao, Xiaofeng
    Liu, Xiaoqing
    Gao, Zhenna
    Wang, Mengyu
    Li, Wenjing
    Pang, Ran
    Yang, Wenqing
    Cao, Zhuoxiao
    Tang, Renhong
    CANCER RESEARCH, 2021, 81 (13)
  • [45] Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy
    Hohjoh, H
    Terada, N
    Kawashima, M
    Honda, Y
    Tokunaga, K
    TISSUE ANTIGENS, 2000, 56 (05): : 446 - 448
  • [46] Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer's Disease
    Orti-Casan, Natalia
    Wu, Yingying
    Naude, Petrus J. W.
    De Deyn, Peter P.
    Zuhorn, Inge S.
    Eisel, Ulrich L. M.
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [47] Anti-human TNFR2 antagonist induces T cell proliferation and restores T cell balance to promote tumor killing in TNFR2 HuGEMMT™ engrafted with MC38/OVA tumor cells.
    He, Daniel X.
    Zheng, Lei
    Sun, Ruilin
    An, Annie X.
    Li, Henry Q. X.
    Ouyang, Davy Xuesong
    CANCER RESEARCH, 2021, 81 (13)
  • [48] Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target
    Medler, Juliane
    Wajant, Harald
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (04) : 295 - 307
  • [49] TNFR2 activates JNK but not MAPK pathways
    Jean-Noel Gouze
    Arthritis Research & Therapy, 4 (1)
  • [50] Dissecting TNFR2 signaling in arteriogenesis and angiogenesis
    He, Yun
    Luo, Dianhong
    Min, Wang
    FASEB JOURNAL, 2007, 21 (05): : A15 - A15
12345